Small Molecule Cancer Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
9
NCT06224738
Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases
Phase: Early Phase 1
Role: Collaborator
Start: Mar 1, 2024
Completion: Mar 1, 2026
Loading map...